These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

921 related items for PubMed ID: 28192212

  • 1. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
    Zhang S, Gao S, Zhao M, Liu Y, Bu Y, Jiang Q, Zhao Q, Ye L, Zhang X.
    Cancer Lett; 2017 Apr 28; 392():94-104. PubMed ID: 28192212
    [Abstract] [Full Text] [Related]

  • 2. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
    Kim HY, Jung HU, Yoo SH, Yoo KS, Cheong J, Park BS, Yun I, Yoo YH.
    Cancer Lett; 2014 Dec 01; 355(1):61-9. PubMed ID: 25218348
    [Abstract] [Full Text] [Related]

  • 3. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G, Chen X, Chen S, Ye W, Hou K, Liang M.
    J Transl Med; 2016 May 05; 14(1):122. PubMed ID: 27150195
    [Abstract] [Full Text] [Related]

  • 4. IFN-α2b inhibits the ethanol enriched-HBV cccDNA through blocking a positive feedback loop of HBx/MSL2/cccDNA/HBV/HBx in liver.
    Liu Z, Wang J, Yuan H, Liu L, Bu Y, Zhao M, Yang G, Feng J, Liu Y, Li J, He Q, Zhang X.
    Biochem Biophys Res Commun; 2020 Jun 18; 527(1):76-82. PubMed ID: 32446394
    [Abstract] [Full Text] [Related]

  • 5. The combination therapy of Peginterferonα and entecavir for HBeAg-positive chronic hepatitis B with high HCC risk.
    Xiong F, Bao X, Gu N, Guo J, Wang J, Ma Y, Yu L, Gao Y, Tan B, Lu J.
    Infect Genet Evol; 2020 Mar 18; 78():104101. PubMed ID: 31689542
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcome of telbivudine versus entecavir in treating higher viral load chronic hepatitis B patients without cirrhosis.
    Pan HY, Pan HY, Song WY, Zheng W, Tong YX, Yang DH, Dai YN, Chen MJ, Wang MS, Huang YC, Zhang JJ, Huang HJ.
    J Viral Hepat; 2017 Nov 18; 24 Suppl 1():29-35. PubMed ID: 29082652
    [Abstract] [Full Text] [Related]

  • 7. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.
    Oncotarget; 2015 Nov 10; 6(35):38093-106. PubMed ID: 26497554
    [Abstract] [Full Text] [Related]

  • 8. Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.
    Tsuge M, Uchida T, Hiraga N, Kan H, Makokha GN, Abe-Chayama H, Miki D, Imamura M, Ochi H, Hayes CN, Shimozono R, Iwamura T, Narumi H, Suzuki T, Kainoh M, Taniguchi T, Chayama K.
    Antimicrob Agents Chemother; 2017 Jun 10; 61(6):. PubMed ID: 28373196
    [Abstract] [Full Text] [Related]

  • 9. HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation.
    Song X, Tan S, Wu Z, Xu L, Wang Z, Xu Y, Wang T, Gao C, Gong Y, Liang X, Gao L, Spear BT, Ma C.
    Int J Cancer; 2018 Dec 15; 143(12):3120-3130. PubMed ID: 29752719
    [Abstract] [Full Text] [Related]

  • 10. Interferon-alpha restrains growth and invasive potential of hepatocellular carcinoma induced by hepatitis B virus X protein.
    Yang JQ, Pan GD, Chu GP, Liu Z, Liu Q, Xiao Y, Yuan L.
    World J Gastroenterol; 2008 Sep 28; 14(36):5564-9; discussion 5568. PubMed ID: 18810776
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT.
    Liu F, You X, Chi X, Wang T, Ye L, Niu J, Zhang X.
    Biochem Biophys Res Commun; 2014 Feb 07; 444(2):128-34. PubMed ID: 24434140
    [Abstract] [Full Text] [Related]

  • 12. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J, Dai X, Zhang H, Zhang W, Sun S, Gao T, Kou Z, Yu H, Guo Y, Du L, Jiang S, Zhang J, Zhou Y.
    Oncotarget; 2015 Oct 06; 6(30):29196-208. PubMed ID: 26470691
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
    Lu JJ, Liu K, Ma YJ, Wang J, Chen EQ, Tang H.
    J Viral Hepat; 2013 Apr 06; 20 Suppl 1():40-5. PubMed ID: 23458523
    [Abstract] [Full Text] [Related]

  • 14. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B, Qian Y, Zhang H, Sang YW, Cheng LF, Wang Q, Gao S, Zheng M, Yao HP.
    World J Gastroenterol; 2016 May 14; 22(18):4538-46. PubMed ID: 27182163
    [Abstract] [Full Text] [Related]

  • 15. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X, Zhao XF, Liang XQ, Chen R, Pan YF, Liang J.
    Biomed Pharmacother; 2017 Jun 14; 90():100-108. PubMed ID: 28343069
    [Abstract] [Full Text] [Related]

  • 16. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs.
    Huang H, Zhou W, Zhu H, Zhou P, Shi X.
    Toxicol Appl Pharmacol; 2017 May 15; 323():36-43. PubMed ID: 28322895
    [Abstract] [Full Text] [Related]

  • 17. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
    Salpini R, Surdo M, Cortese MF, Palumbo GA, Carioti L, Cappiello G, Spanò A, Trimoulet P, Fleury H, Vecchiet J, Pasquazzi C, Mirabelli C, Scutari R, Sacco A, Alkhatib M, Missale G, Francioso S, Sarmati L, Andreoni M, Angelico M, Ceccherini-Silberstein F, Levrero M, Perno CF, Belloni L, Svicher V.
    Clin Microbiol Infect; 2019 Jul 15; 25(7):906.e1-906.e7. PubMed ID: 30472417
    [Abstract] [Full Text] [Related]

  • 18. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
    Liu Z, Li G, Gou Y, Xiao D, Luo G, Saavedra JE, Liu J, Wang H.
    Biomed Pharmacother; 2017 Aug 15; 92():989-997. PubMed ID: 28605880
    [Abstract] [Full Text] [Related]

  • 19. Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA.
    Kim DH, Choi JW, Seo JH, Cho YS, Won SY, Park BK, Jeon HH, Shin SY, Lee CK.
    Yonsei Med J; 2017 May 15; 58(3):552-556. PubMed ID: 28332360
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
    Lu ZP, Xiao ZL, Yang Z, Li J, Feng GX, Chen FQ, Li YH, Feng JY, Gao YE, Ye LH, Zhang XD.
    Acta Pharmacol Sin; 2015 Oct 15; 36(10):1228-36. PubMed ID: 26073327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.